ATE403746T1 - Diagnose von restenose - Google Patents

Diagnose von restenose

Info

Publication number
ATE403746T1
ATE403746T1 AT00937731T AT00937731T ATE403746T1 AT E403746 T1 ATE403746 T1 AT E403746T1 AT 00937731 T AT00937731 T AT 00937731T AT 00937731 T AT00937731 T AT 00937731T AT E403746 T1 ATE403746 T1 AT E403746T1
Authority
AT
Austria
Prior art keywords
restenosis
diagnosis
predisposed
kits
subject
Prior art date
Application number
AT00937731T
Other languages
English (en)
Inventor
Kenneth Kornman
Gordon Duff
David Crossman
Sheila Francis
Katherine Stephenson
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/431,352 external-priority patent/US6524795B1/en
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Application granted granted Critical
Publication of ATE403746T1 publication Critical patent/ATE403746T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/323Arteriosclerosis, Stenosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Sorption Type Refrigeration Machines (AREA)
AT00937731T 1999-05-24 2000-05-24 Diagnose von restenose ATE403746T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31767499A 1999-05-24 1999-05-24
US09/431,352 US6524795B1 (en) 1997-03-10 1999-11-01 Diagnostics for cardiovascular disorders

Publications (1)

Publication Number Publication Date
ATE403746T1 true ATE403746T1 (de) 2008-08-15

Family

ID=26981080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00937731T ATE403746T1 (de) 1999-05-24 2000-05-24 Diagnose von restenose

Country Status (8)

Country Link
EP (1) EP1192277B1 (de)
JP (1) JP2003500069A (de)
AT (1) ATE403746T1 (de)
AU (1) AU782836B2 (de)
CA (1) CA2374531A1 (de)
DE (1) DE60039760D1 (de)
ES (1) ES2311459T3 (de)
WO (1) WO2000071753A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820383B2 (en) 1997-03-10 2010-10-26 Interleukin Genetics, Inc. Method for diagnosing myocardial infarction
US6524795B1 (en) * 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
US7306913B2 (en) * 2002-12-20 2007-12-11 Applera Corporation Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof
US7625699B2 (en) 2003-03-10 2009-12-01 Celera Corporation Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof
WO2004100987A2 (en) * 2003-05-06 2004-11-25 Regeneron Pharmaceuticals, Inc. Methods of using il-1 antagonists to treat neointimal hyperplasia
EP1753875A2 (de) * 2004-05-07 2007-02-21 Applera Corporation Genetische polymorphismen, die mit gefässerkrankungen einhergehen, nachweisverfahren und verwendung
US9668969B1 (en) 2012-02-22 2017-06-06 Arturo Solis Herrera Methods of using QIAPINE
AU2013327501B2 (en) * 2012-10-04 2018-08-09 Xbiotech Inc. Treating vascular disease and complications thereof
RU2740444C1 (ru) * 2020-07-17 2021-01-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ прогнозирования развития тромботических осложнений после реконструктивно-восстановительных вмешательств на магистральных артериях нижних конечностей
CN116889630B (zh) * 2023-08-22 2025-08-26 温州医科大学 Pai-1抑制剂在制备肝脏缺血再灌注损伤治疗药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210877B1 (en) * 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease

Also Published As

Publication number Publication date
AU5286700A (en) 2000-12-12
ES2311459T3 (es) 2009-02-16
JP2003500069A (ja) 2003-01-07
DE60039760D1 (de) 2008-09-18
AU782836B2 (en) 2005-09-01
EP1192277B1 (de) 2008-08-06
EP1192277A2 (de) 2002-04-03
WO2000071753A2 (en) 2000-11-30
WO2000071753A3 (en) 2002-02-07
CA2374531A1 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
DE60039760D1 (de) Diagnose von Restenose
IL142438A0 (en) Diagnostic and therapeutics for sepsis
WO2001000880A3 (en) Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
ATE339196T1 (de) Zelladhäsionsinhibitoren
NO20002844L (no) Forbedret elektrokjemisk biosensorteststrimmel
ATE317913T1 (de) Beobachtung von verbindungen mittels elektrochemilumineszenz
ATE351921T1 (de) Verfahren für fluoreszenzerkennungstest
ATE376187T1 (de) Nachweis von erkrankungen der nieren und behandlung
DE60044114D1 (de) Wegwerfartikel zum Aufnehmen von Urin für den Mann
DE60041315D1 (de) Wegwerfartikel zum Aufnehmen von Urin für den Mann
FI973115A7 (fi) Pariston kunnon testauslaite
EA199800405A1 (ru) Переносной прибор для определения оптимального времени зачатия
DE59805687D1 (de) Fell für Schlaginstrument
ATE343597T1 (de) Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie
ATE271225T1 (de) Verwendung von urintrypsininhibitor zur diagnose von aids
EA200200435A1 (ru) Анализ лептина
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
ATE496140T1 (de) Methoden und sondensätze zur bestimmung einer prognose von prostatakrebs
ATE392619T1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
ATE334227T1 (de) Elektrochemilumineszenz-helikasetest
NO20002176D0 (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom
FI951778A0 (fi) Menetelmä allergian toteamiseksi
DE60235576D1 (de) Diagnostikum für die frühe phase von morbus alzheimer
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
EP1567045A4 (de) Verfahren zur diagnostizierung des vorliegens bzw. stadiums von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties